不适合移植的大 B 细胞淋巴瘤二线使用 axicabtagene ciloleucel:ALYCANTE 最终分析
Second-line axicabtagene ciloleucel in large B-cell lymphoma ineligible for transplantation: ALYCANTE final analysis.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Fifth Edition of the World Health Organization Classification of Tumors of the Hematopoietic and Lymphoid Tissues: Mature T-Cell, NK-Cell, and Stroma-Derived Neoplasms of Lymphoid Tissues.
Fifth Edition of the World Health Organization Classification of Tumors of the Hematopoietic and Lymphoid Tissues: Mature T-Cell, NK-Cell, and Stroma-Derived Neoplasms of Lymphoid Tissues.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
本综述聚焦于第五版世界卫生组织造血淋巴肿瘤分类中的成熟T细胞、自然杀伤(NK)细胞及间质来源肿瘤,包括与修订第四版相比的变化。总体而言,信息量有所扩展,主要归因于基因组学认识的进步。更新后的分类采用层级格式。更新后的分类依赖于多学科方法,整合了来自不同病理学家、临床医生和遗传学家的见解。胃肠道惰性NK细胞淋巴增殖性疾病、EB病毒阳性结内T细胞和NK细胞淋巴瘤以及若干淋巴组织间质来源肿瘤被新引入或纳入。本综述还为第五版世界卫生组织造血淋巴肿瘤分类如何在常规临床实践中应用提供了指导。
This review focuses on mature T cells, natural killer (NK) cells, and stroma-derived neoplasms in the fifth edition of the World Health Organization classification of hematolymphoid tumors, including changes from the revised fourth edition.
Overall, information has expanded, primarily due to advancements in genomic understanding. The updated classification adopts a hierarchical format. The updated classification relies on a multidisciplinary approach, incorporating insights from a diverse group of pathologists, clinicians, and geneticists.
Indolent NK-cell lymphoproliferative disorder of the gastrointestinal tract, Epstein-Barr virus-positive nodal T- and NK-cell lymphoma, and several stroma-derived neoplasms of lymphoid tissues have been newly introduced or included. The review also provides guidance on how the fifth edition of the World Health Organization classification of hematolymphoid tumors can be applied in routine clinical practice.
MEMBER ACCOUNT
登录成功会直接打开下一页。